Data Mining Technical Publications to Rank the Innovators in RNA Therapeutics

Specialists lead the RNA intellectual property ecosystem but may still need big pharma to bring new treatments to market making the space ripe for partnerships, mergers and acquisitions

2021 saw a significant jump in RNA based trials. Large sequencing projects and the success of mRNA COVID-19 vaccines should drive the growth of the global RNA therapeutics market.
Our analysis suggests that Moderna Inc (MRNA US) , Vertex Pharmaceuticals (VRTX US), Incyte Corp (INCY US), Alnylam Pharmaceuticals (ALNY US), Ionis Pharmaceuticals (IONS US) lead in RNA therapy related innovations.
R&D collaboration, licensing deals, strategic investments and buyouts between RNA specialists and big pharma will increase as sitting on the sidelines might no longer be an option.

Full analysis here:- https://www.smartkarma.com/insights/data-mining-technical-publications-to-rank-the-innovators-in-rna-therapeutics?utm_source=tiger_community

By Pyari Menon, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/pyari-menon?utm_source=tiger_community

On Thematic (Sector/Industry) - https://www.smartkarma.com/collections/thematic-strategy?utm_source=tiger_community

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

Wait_Flowers
2022-07-24
Wait_Flowers
这篇文章不错，转发给大家看
神奇财妈
2022-07-15
神奇财妈
学习
Shirley磊
2022-07-15
Shirley磊
强
LJ888888
2022-07-15
LJ888888
6
A灋一
2022-07-15
A灋一
好厉害啊
逸逸外婆
2022-07-15
逸逸外婆
已阅

发表看法

14

296

15

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":688644658,"tweetId":"688644658","gmtCreate":1657639240000,"gmtModify":1704867867770,"author":{"id":4103332230805300,"idStr":"4103332230805300","authorId":4103332230805300,"authorIdStr":"4103332230805300","name":"Smartkarma","avatar":"https://static.tigerbbs.com/bb92df7ff435380d798b36afa44a5c07","vip":5,"userType":5,"introduction":"Smartkarma官方账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":356,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"Data Mining Technical Publications to Rank the Innovators in RNA Therapeutics","extraTitle":"","html":"<html><head></head><body><p><b>Specialists lead the RNA intellectual property ecosystem but may still need big pharma&nbsp; to bring new treatments to market making the space ripe for partnerships, mergers and acquisitions</b></p> <ul> \n <li>2021 saw a significant jump in RNA based trials. Large sequencing projects and the success of mRNA COVID-19 vaccines should drive the growth of the global RNA therapeutics market.&nbsp;</li> \n <li>Our analysis suggests that Moderna Inc (MRNA US) , Vertex Pharmaceuticals (VRTX US),&nbsp;Incyte Corp (INCY US), Alnylam Pharmaceuticals (ALNY US), Ionis Pharmaceuticals (IONS US) lead in RNA therapy related innovations.</li> \n <li>R&amp;D collaboration, licensing deals, strategic investments and buyouts between RNA specialists and big pharma will increase as sitting on the sidelines might no longer be an option.</li> \n</ul> <p>Full analysis here:- https://www.smartkarma.com/insights/data-mining-technical-publications-to-rank-the-innovators-in-rna-therapeutics?utm_source=tiger_community</p> <p>By Pyari Menon, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/pyari-menon?utm_source=tiger_community</p> <p>On Thematic (Sector/Industry) - https://www.smartkarma.com/collections/thematic-strategy?utm_source=tiger_community</p></body></html>","htmlText":"<html><head></head><body><p><b>Specialists lead the RNA intellectual property ecosystem but may still need big pharma&nbsp; to bring new treatments to market making the space ripe for partnerships, mergers and acquisitions</b></p> <ul> \n <li>2021 saw a significant jump in RNA based trials. Large sequencing projects and the success of mRNA COVID-19 vaccines should drive the growth of the global RNA therapeutics market.&nbsp;</li> \n <li>Our analysis suggests that Moderna Inc (MRNA US) , Vertex Pharmaceuticals (VRTX US),&nbsp;Incyte Corp (INCY US), Alnylam Pharmaceuticals (ALNY US), Ionis Pharmaceuticals (IONS US) lead in RNA therapy related innovations.</li> \n <li>R&amp;D collaboration, licensing deals, strategic investments and buyouts between RNA specialists and big pharma will increase as sitting on the sidelines might no longer be an option.</li> \n</ul> <p>Full analysis here:- https://www.smartkarma.com/insights/data-mining-technical-publications-to-rank-the-innovators-in-rna-therapeutics?utm_source=tiger_community</p> <p>By Pyari Menon, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/pyari-menon?utm_source=tiger_community</p> <p>On Thematic (Sector/Industry) - https://www.smartkarma.com/collections/thematic-strategy?utm_source=tiger_community</p></body></html>","text":"Specialists lead the RNA intellectual property ecosystem but may still need big pharma to bring new treatments to market making the space ripe for partnerships, mergers and acquisitions 2021 saw a significant jump in RNA based trials. Large sequencing projects and the success of mRNA COVID-19 vaccines should drive the growth of the global RNA therapeutics market. Our analysis suggests that Moderna Inc (MRNA US) , Vertex Pharmaceuticals (VRTX US), Incyte Corp (INCY US), Alnylam Pharmaceuticals (ALNY US), Ionis Pharmaceuticals (IONS US) lead in RNA therapy related innovations. R&D collaboration, licensing deals, strategic investments and buyouts between RNA specialists and big pharma will increase as sitting on the sidelines might no longer be an option. Full analysis here:- https://www.smartkarma.com/insights/data-mining-technical-publications-to-rank-the-innovators-in-rna-therapeutics?utm_source=tiger_community By Pyari Menon, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/pyari-menon?utm_source=tiger_community On Thematic (Sector/Industry) - https://www.smartkarma.com/collections/thematic-strategy?utm_source=tiger_community","highlighted":2,"essential":1,"paper":2,"likeSize":296,"commentSize":14,"repostSize":15,"favoriteSize":0,"link":"https://laohu8.com/post/688644658","repostId":0,"isVote":1,"tweetType":1,"viewCount":44468,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["RNA"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1033,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":7556359,"commentId":"7556359","gmtCreate":1658619860934,"gmtModify":1658619861711,"authorId":3458084208518407,"author":{"id":3458084208518407,"idStr":"3458084208518407","authorId":3458084208518407,"name":"Wait_Flowers","avatar":"https://static.laohu8.com/faca4ffb24cf0ef84548e8a47b1cd984","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":688644658,"objectIdStr":"688644658","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"这篇文章不错，转发给大家看","text":"这篇文章不错，转发给大家看","html":"这篇文章不错，转发给大家看","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":7539895,"commentId":"7539895","gmtCreate":1657896378593,"gmtModify":1657896379384,"authorId":4090582168976430,"author":{"id":4090582168976430,"idStr":"4090582168976430","authorId":4090582168976430,"name":"神奇财妈","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":688644658,"objectIdStr":"688644658","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"学习","text":"学习","html":"学习","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0},{"id":7539870,"commentId":"7539870","gmtCreate":1657895542693,"gmtModify":1657895543579,"authorId":3491036623178824,"author":{"id":3491036623178824,"idStr":"3491036623178824","authorId":3491036623178824,"name":"Shirley磊","avatar":"https://static.tigerbbs.com/c0662b86a2cd2859f3d83297e0c8ff7f","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":688644658,"objectIdStr":"688644658","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"强","text":"强","html":"强","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0},{"id":7539510,"commentId":"7539510","gmtCreate":1657881769631,"gmtModify":1657881770581,"authorId":4110007136516972,"author":{"id":4110007136516972,"idStr":"4110007136516972","authorId":4110007136516972,"name":"LJ888888","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":688644658,"objectIdStr":"688644658","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"6","text":"6","html":"6","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0},{"id":7538918,"commentId":"7538918","gmtCreate":1657859515853,"gmtModify":1657859516819,"authorId":4091612576314620,"author":{"id":4091612576314620,"idStr":"4091612576314620","authorId":4091612576314620,"name":"A灋一","avatar":"https://static.tigerbbs.com/540678673bf2ed5d479d0674b60601c5","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":688644658,"objectIdStr":"688644658","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"好厉害啊","text":"好厉害啊","html":"好厉害啊","likeSize":2,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0},{"id":7538838,"commentId":"7538838","gmtCreate":1657856635758,"gmtModify":1657856636468,"authorId":3583527971491170,"author":{"id":3583527971491170,"idStr":"3583527971491170","authorId":3583527971491170,"name":"逸逸外婆","avatar":"https://static.tigerbbs.com/77188233721f103aada2e0adb3c911df","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":688644658,"objectIdStr":"688644658","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"已阅","text":"已阅","html":"已阅","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/688644658"}